135 related articles for article (PubMed ID: 24975363)
1. Estimation of electrokinetic and hydrodynamic global properties of relevant amyloid-beta peptides through the modeling of their effective electrophoretic mobilities and analysis of their propensities to aggregation.
Deiber JA; Piaggio MV; Peirotti MB
J Sep Sci; 2014 Sep; 37(18):2618-24. PubMed ID: 24975363
[TBL] [Abstract][Full Text] [Related]
2. Global properties and propensity to dimerization of the amyloid-beta (12-28) peptide fragment through the modeling of its monomer and dimer diffusion coefficients and electrophoretic mobilities.
Deiber JA; Peirotti MB; Piaggio MV
Electrophoresis; 2015 Mar; 36(5):805-12. PubMed ID: 25403948
[TBL] [Abstract][Full Text] [Related]
3. Charge regulation phenomenon predicted from the modeling of polypeptide electrophoretic mobilities as a relevant mechanism of amyloid-beta peptide oligomerization.
Deiber JA; Peirotti MB; Piaggio MV
Electrophoresis; 2016 Mar; 37(5-6):711-8. PubMed ID: 26718015
[TBL] [Abstract][Full Text] [Related]
4. In vitro monitoring of amyloid β-peptide oligomerization by Electrospray differential mobility analysis: An alternative tool to evaluate Alzheimer's disease drug candidates.
Brinet D; Gaie-Levrel F; Delatour V; Kaffy J; Ongeri S; Taverna M
Talanta; 2017 Apr; 165():84-91. PubMed ID: 28153323
[TBL] [Abstract][Full Text] [Related]
5. Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation.
Abelein A; Gräslund A; Danielsson J
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5407-12. PubMed ID: 25825723
[TBL] [Abstract][Full Text] [Related]
6. Aggregation States of A
Festa G; Mallamace F; Sancesario GM; Corsaro C; Mallamace D; Fazio E; Arcidiacono L; Garcia Sakai V; Senesi R; Preziosi E; Sancesario G; Andreani C
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450543
[TBL] [Abstract][Full Text] [Related]
7. A discrete mathematical model for the aggregation of β-Amyloid.
Dayeh MA; Livadiotis G; Elaydi S
PLoS One; 2018; 13(5):e0196402. PubMed ID: 29791461
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths.
Snyder SW; Ladror US; Wade WS; Wang GT; Barrett LW; Matayoshi ED; Huffaker HJ; Krafft GA; Holzman TF
Biophys J; 1994 Sep; 67(3):1216-28. PubMed ID: 7811936
[TBL] [Abstract][Full Text] [Related]
9. pH-controlled aggregation polymorphism of amyloidogenic Aβ(16-22): insights for obtaining peptide tapes and peptide nanotubes, as function of the N-terminal capping moiety.
Elgersma RC; Kroon-Batenburg LM; Posthuma G; Meeldijk JD; Rijkers DT; Liskamp RM
Eur J Med Chem; 2014 Dec; 88():55-65. PubMed ID: 25087966
[TBL] [Abstract][Full Text] [Related]
10. β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis.
Francioso A; Punzi P; Boffi A; Lori C; Martire S; Giordano C; D'Erme M; Mosca L
Bioorg Med Chem; 2015 Apr; 23(8):1671-83. PubMed ID: 25769517
[TBL] [Abstract][Full Text] [Related]
11. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
12. In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.
Benseny-Cases N; Klementieva O; Cladera J
Subcell Biochem; 2012; 65():53-74. PubMed ID: 23224999
[TBL] [Abstract][Full Text] [Related]
13. Biophysical comparison of soluble amyloid-β(1-42) protofibrils, oligomers, and protofilaments.
Nichols MR; Colvin BA; Hood EA; Paranjape GS; Osborn DC; Terrill-Usery SE
Biochemistry; 2015 Apr; 54(13):2193-204. PubMed ID: 25756466
[TBL] [Abstract][Full Text] [Related]
14. Determination of critical nucleation number for a single nucleation amyloid-β aggregation model.
Ghosh P; Vaidya A; Kumar A; Rangachari V
Math Biosci; 2016 Mar; 273():70-9. PubMed ID: 26774039
[TBL] [Abstract][Full Text] [Related]
15. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
[TBL] [Abstract][Full Text] [Related]
16. A method for evaluating the level of soluble β-amyloid(1-40/1-42) in Alzheimer's disease based on the binding of gelsolin to β-amyloid peptides.
Yu Y; Zhang L; Li C; Sun X; Tang D; Shi G
Angew Chem Int Ed Engl; 2014 Nov; 53(47):12832-5. PubMed ID: 25244702
[TBL] [Abstract][Full Text] [Related]
17. A cyclic KLVFF-derived peptide aggregation inhibitor induces the formation of less-toxic off-pathway amyloid-β oligomers.
Arai T; Sasaki D; Araya T; Sato T; Sohma Y; Kanai M
Chembiochem; 2014 Nov; 15(17):2577-83. PubMed ID: 25262917
[TBL] [Abstract][Full Text] [Related]
18. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
[TBL] [Abstract][Full Text] [Related]
19. Electrohydrodynamic properties of succinoglycan as probed by fluorescence correlation spectroscopy, potentiometric titration and capillary electrophoresis.
Duval JF; Slaveykova VI; Hosse M; Buffle J; Wilkinson KJ
Biomacromolecules; 2006 Oct; 7(10):2818-26. PubMed ID: 17025358
[TBL] [Abstract][Full Text] [Related]
20. [Physico-chemical methods for studing β-amyloid aggregation].
Radko SP; Khmeleva SA; Suprun EV; Kozin SA; Bodoev NV; Makarov AA; Archakov AI; Shumyantseva VV
Biomed Khim; 2015; 61(2):203-18. PubMed ID: 25978387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
